Ventilator-associated Pneumonia
Conditions
Brief summary
Ventilator-associated pneumonia is the leading cause of nosocomial infection in the ICU. The pathogens responsible are multiple, but enterobacteria constitute a major source of pathogens involved. Within this family, Klebsiella spp. and Escherichia coli are the two most frequent genera, with Klebsiella spp. often present in severe forms. The factors associated with the occurrence of Ventilator-associated pneumonia and its adverse course depend on host defenses and the virulence of the pathogen. The virulence of Klebsiella spp. depends on several structures, notably the presence of a capsule, the particularities of its lipopolysaccharide, its adhesins (type 3 fimbriae), its capacity to capture iron (siderophores). The objective of this work is to evaluate the role of these different virulence mechanisms in the evolution of Ventilator-associated pneumonia and the hospital prognosis.
Interventions
None listed
Sponsors
Fondation Hôpital Saint-Joseph
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Patient whose age is ≥ 18 years * Patient hospitalized in an intensive care unit * Patient with ventilator-associated Klebsiella spp. pneumonia * French-speaking patient
Exclusion criteria
* Patient with a severe psychiatric disorder * Patient under guardianship or curatorship * Patient deprived of liberty * Patient under court protection * Patient who objects to the use of his or her data for this research
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Role of 2-hydroxymyristate within lipid A of lipopolysaccharide in the prognosis of mechanically ventilated pneumonia caused by Klebsiella spp. | Month 1 | This outcome corresponds to the prognostic value (prediction of clinical cure) of the studied virulence parameters (myristate hydroxylation, presence of fimbriae, expression of siderophores, expression of capsule) at D7 of effective antibiotic treatment, according to the virulence parameters of the pathogen, after adjustment on known prognostic factors. This value will be estimated by the adjusted HR, the improvement of the model fit, the number of patients who change classification (cured/not cured) after inclusion of this factor. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Effect of other virulence factors on the evolution of ventilator-associated pneumonia | Month 1 | This outcome corresponds to the prognostic value (accuracy of recurrence of pulmonary infection under mechanical ventilation with the same germ (Klebsiella spp.) during the stay in intensive care. |
Countries
France
Contacts
Primary ContactFrançois PHILIPPART, MD
Backup ContactHelene BEAUSSIER, PharmD, PhD
Outcome results
None listed